RecruitingNot ApplicableNCT07171658

Breast Cancer-Related Approach for Increasing Cervical Cancer Screening

Improving Cervical Cancer Screening Coverage Among Underscreened Women Aged 50 to 74 in Switzerland Using HPV Self-sampling Strategies: A Randomized Study - Breast Cancer-Related Approach for Increasing Cervical Cancer Screening

Sponsor

Jessica Di Vincenzo Sormani

Enrollment

4,500 participants

Start Date

Oct 7, 2025

Study Type

INTERVENTIONAL

Conditions

Cervical Cancer Screening

Summary

The primary objective of this clinical trial is to assess cervical cancer screening participation among under-screened women invited through organized breast cancer screening programs in Switzerland. This randomized trial will compare three arms: 1. Intervention group 1: Sensitization to Cervical Cancer (CC) screening Women will receive an awareness letter explaining the importance of cervical cancer screening, the Swiss recommendations and an invitation to schedule an appointment. 2. Intervention group 2: Home-based Human papillomavirus infection (HPV) self-sampling Women will receive a free-of-charge vaginal self-sampling kit for HPV infection 3. Observational control group Women selected in the control arm will only be recruited one year following the screening of those in the intervention arm (T0+1), as to not influence Cervical Cancer Screening (CCS) behavior during this period by being reminded of screening recommendations.

Eligibility

Sex: FEMALEMin Age: 50 YearsMax Age: 74 Years

Plain Language Summary

Simplified for easier understanding

This trial tests whether sending cervical cancer screening reminders to women who are already receiving breast cancer screening invitations increases the number of women who get both screenings done. **You may be eligible if...** - You are a woman between 50 and 74 years old living in one of five Swiss cantons - You have been invited for breast cancer screening - You have not had a cervical cancer screening in the past 3 years - You speak French, German, Italian, English, Spanish, or Portuguese **You may NOT be eligible if...** - You have previously been diagnosed with cervical cancer - You have had a hysterectomy - You do not consent to participate - You are pregnant - You are under guardianship or lack decision-making capacity Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALSensitization to Cervical Cancer (CC) screening

Women will receive an awareness letter explaining the importance of cervical cancer screening, the Swiss recommendations and an invitation to schedule an appointment.

BEHAVIORALHome-based HPV self-sampling

Women will receive a free-of-charge vaginal self-sampling kit for HPV infection.

Locations(1)

University Hospitals of Geneva

Geneva, Canton of Geneva, Switzerland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07171658

Related Trials

Community Co-produced Action for Improved Access to Cervical Cancer Screening in Cameroon

NCT066400751 location

Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women

NCT074513401 location

Using Artificial Intelligence-based ChatBot to Improve Women's Participation to Cervical Cancer Screening Programme

NCT052860341 location

Ameliorated Pap Tests and Cervical Cancer Screening Participation

NCT069688715 locations

Compliance to Cervical Cancer Chemoradiation Guidelines: A Multicentric Implementation Audit and Resource Assessment Initiative of National Cancer Grid of India

NCT072909722 locations